Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressants

Abstract Background: Recent publications have raised questions over the efficacy and clinically relevant effects of antidepressants that have been approved for the treatment of major depression. In this context, the European Commission requested that the European Medicines Agency (EMEA) and its scie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European neuropsychopharmacology 2009-05, Vol.19 (5), p.305-308
1. Verfasser:	Broich, Karl
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressants Antidepressive Agents - therapeutic use CHMP Committee for Medicinal Products for Human Use Depressive Disorder, Major - drug therapy Drug Approval - organization & administration Drug evaluation Drug Evaluation - methods Drug Evaluation - standards EMEA Europe European Medicines Agency Federal Government Humans Internal Medicine Major depression Meta-Analysis as Topic Psychiatry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!